Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dropping GPOs: Medtronic's Hawkins Expects More Of It From MedTech

This article was originally published in The Gray Sheet

Executive Summary

Medtronic CEO Bill Hawkins says he would be "shocked" if some competitors did not follow his firm's lead this year with cancellations of large group purchasing organization contracts.

You may also be interested in...



Medtronic: Bulk ICD Orders Down, But GPO Decision Not To Blame

Medtronic says it received noticeably fewer bulk orders from hospitals for cardiac rhythm management devices in its most recent fiscal quarter, but insists the outcome was not related to its decision to cancel certain large group purchasing organization contracts.

Medtronic: Bulk ICD Orders Down, But GPO Decision Not To Blame

Medtronic says it received noticeably fewer bulk orders from hospitals for cardiac rhythm management devices in its most recent fiscal quarter, but insists the outcome was not related to its decision to cancel certain large group purchasing organization contracts.

Baucus Examines Medtronic's GPO Contract Cancellations

Sen. Max Baucus is investigating Medtronic's decision earlier this year to cancel several large contracts with hospital group purchasing organizations out of concerns that the firm's actions could increase costs and reduce price transparency in the health care system.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029904

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel